MaxCyte, Inc. ( MXCT) - Stock Earnings
MXCT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 12, 2026, midnight | — / — | — | — / — | — |
MXCT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -12.4 million USD | 6.8 million USD |
| 2025Q4 | -9.6 million USD | 7.3 million USD |
| 2026Q1 | -4.8 million USD | 9.7 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
MXCT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -37.9 million USD | 41.3 million USD |
| 2024 | -41.1 million USD | 38.6 million USD |
| 2025 | -44.6 million USD | 33.0 million USD |
| 2026 Est. | — | — |
MXCT
Price: $1.08
52 week price:
Earnings Per Share: -0.36 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 508900
Market Capitalization: 130.2 million